EMD emyria limited
Add to My Watchlist 3.57% ! 2.7¢

An MDMA analogue which could end up in direct competition with...

  1. reon1
    1,720 Posts.
    lightbulb Created with Sketch. 540
    clock Created with Sketch.
    20/06/24
    09:01
    Post #: 74402338
    An MDMA analogue which could end up in direct competition with Emyria's own ones. Very strange.

    All to generate some professional fees. Emeryia has changed so much from a promising biotech to a clinical service provider.
    Last edited by reon1: 20/06/24
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Significant new gold-copper discovery at Minyari Dome delivers high-grade results
right-arrow Created with Sketch.
NEWS Outstanding Drill Results Define New High-Grade Iris Zone at Apollo Hill
right-arrow Created with Sketch.
NEWS High-Grade Niobium Intercept Delivered by Initial Drilling at Joyce
right-arrow Created with Sketch.
NEWS Proteomics International granted first patent for endometriosis diagnostic blood test in Japan
right-arrow Created with Sketch.
NEWS Next Science to Sell Majority of Assets in Proposed Transaction
right-arrow Created with Sketch.
ACW Actinogen Confirms 100th Participant in Alzheimer’s Disease Trial and Interim Analysis Timeline
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
2.7¢ 		Change
-0.001(3.57%) 		Mkt cap ! $16.50M
Open High Low Value Volume
2.7¢ 2.8¢ 2.6¢ $29.59K 1.096M

Buyers (Bids)

No. Vol. Price($)
2 4919 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 1363075 5
View Market Depth
Last trade - 13.02pm 01/07/2025 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.